Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells

End Stage Renal Disease (ESRD) is an ever increasing problem worldwide. However the mechanisms underlying disease progression are not fully elucidated. This work addressed nephrotoxicity induced by the immunosuppressive agents’ cyclosporine A (CsA) and sirolimus (SRL). Nephrotoxicity is the major li...

Full description

Saved in:
Bibliographic Details
Main Authors: Séin O'Connell, Craig Slattery, Michael P. Ryan, Tara McMorrow
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2012/980910
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562662676889600
author Séin O'Connell
Craig Slattery
Michael P. Ryan
Tara McMorrow
author_facet Séin O'Connell
Craig Slattery
Michael P. Ryan
Tara McMorrow
author_sort Séin O'Connell
collection DOAJ
description End Stage Renal Disease (ESRD) is an ever increasing problem worldwide. However the mechanisms underlying disease progression are not fully elucidated. This work addressed nephrotoxicity induced by the immunosuppressive agents’ cyclosporine A (CsA) and sirolimus (SRL). Nephrotoxicity is the major limiting factor in long term use of CsA. SRL causes less nephrotoxicity than CsA. Therefore investigations into the differential effects of these agents may identify potential mechanisms of nephrotoxicity and means to prevent ESRD induced by therapeutic drugs. Using ELISA, Western blotting, quantitative PCR and a reporter gene assay we detailed the differential effects of CsA and SRL in human renal mesangial cells. CsA treatment increased profibrotic TGF-β1 secretion in human mesangial cells whereas SRL did not, indicating a role for TGF-β in CsA toxicity. However we observed a synergistic nephrotoxic effect when CsA and SRL were co-administered. These synergistic alterations may have been due to an increase in CTGF which was not evident when the immunosuppressive drugs were used alone. The CsA/SRL combination therapy significantly enhanced Smad signalling and altered the extracellular matrix regulator matrix metalloproteinase 9 (MMP-9). Inhibition of the ERK 1/2 pathway, attenuated these CsA/SRL induced alterations indicating a potentially significant role for this pathway.
format Article
id doaj-art-2be951a7ab6d48a980b38977669fd7c6
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-2be951a7ab6d48a980b38977669fd7c62025-02-03T01:22:01ZengWileyJournal of Transplantation2090-00072090-00152012-01-01201210.1155/2012/980910980910Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial CellsSéin O'Connell0Craig Slattery1Michael P. Ryan2Tara McMorrow3Renal Disease Research Group, UCD School of Biomolecular and Biomedical Research, UCD Conway Institute, University College Dublin, Dublin, IrelandRenal Disease Research Group, UCD School of Biomolecular and Biomedical Research, UCD Conway Institute, University College Dublin, Dublin, IrelandRenal Disease Research Group, UCD School of Biomolecular and Biomedical Research, UCD Conway Institute, University College Dublin, Dublin, IrelandRenal Disease Research Group, UCD School of Biomolecular and Biomedical Research, UCD Conway Institute, University College Dublin, Dublin, IrelandEnd Stage Renal Disease (ESRD) is an ever increasing problem worldwide. However the mechanisms underlying disease progression are not fully elucidated. This work addressed nephrotoxicity induced by the immunosuppressive agents’ cyclosporine A (CsA) and sirolimus (SRL). Nephrotoxicity is the major limiting factor in long term use of CsA. SRL causes less nephrotoxicity than CsA. Therefore investigations into the differential effects of these agents may identify potential mechanisms of nephrotoxicity and means to prevent ESRD induced by therapeutic drugs. Using ELISA, Western blotting, quantitative PCR and a reporter gene assay we detailed the differential effects of CsA and SRL in human renal mesangial cells. CsA treatment increased profibrotic TGF-β1 secretion in human mesangial cells whereas SRL did not, indicating a role for TGF-β in CsA toxicity. However we observed a synergistic nephrotoxic effect when CsA and SRL were co-administered. These synergistic alterations may have been due to an increase in CTGF which was not evident when the immunosuppressive drugs were used alone. The CsA/SRL combination therapy significantly enhanced Smad signalling and altered the extracellular matrix regulator matrix metalloproteinase 9 (MMP-9). Inhibition of the ERK 1/2 pathway, attenuated these CsA/SRL induced alterations indicating a potentially significant role for this pathway.http://dx.doi.org/10.1155/2012/980910
spellingShingle Séin O'Connell
Craig Slattery
Michael P. Ryan
Tara McMorrow
Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
Journal of Transplantation
title Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
title_full Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
title_fullStr Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
title_full_unstemmed Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
title_short Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
title_sort sirolimus enhances cyclosporine a induced cytotoxicity in human renal glomerular mesangial cells
url http://dx.doi.org/10.1155/2012/980910
work_keys_str_mv AT seinoconnell sirolimusenhancescyclosporineainducedcytotoxicityinhumanrenalglomerularmesangialcells
AT craigslattery sirolimusenhancescyclosporineainducedcytotoxicityinhumanrenalglomerularmesangialcells
AT michaelpryan sirolimusenhancescyclosporineainducedcytotoxicityinhumanrenalglomerularmesangialcells
AT taramcmorrow sirolimusenhancescyclosporineainducedcytotoxicityinhumanrenalglomerularmesangialcells